Pipeline Moves: Further study shot of three cancer assets reviewed after early phase terminations
Early phase study completions in Huntington’s disease and obstructive sleep apnoea are also reviewed.
By
Clinical Trials Arena Team
All Articles
Pipeline Moves: Merck KGaA’s berzosertib progression shot in small-cell lung cancer reviewed after Phase II discontinued
We also review berzosertib in solid tumours, as well as other assets in myelodysplastic syndrome, cervical cancer, and Dengue…
By
Pipeline Moves: Eledon’s advancement shot in ALS reviewed after Phase IIa data reveal
The Clinical Trials Arena team also dig into benign tumours, hepatitis B, lymphomas, myelofibrosis, polycythemia vera, and soft tissue…
By
Pipeline Moves: Myelodysplastic syndrome study on partial hold, solid tumour trial terminated
We also take a look at the suspension of a Tecentriq combo trial, and a small-cell lung cancer study…
By